Pharmaron Acquires Absorption Systems

Ellab Acquires PharmaSys, Inc.

May 3, 2023

Healthcare Services

Ellab has acquired PharmaSys, Inc., a Raleigh, North Carolina-based validation and CQV services firm with 17 employees, as part of Ellab's strategy to expand its US field services in the biopharma sector. The PharmaSys owners, Nancy K. Lankford and Charles L. Lankford, will remain through the transition before retiring this summer.

Pharmacosmos A/S Acquires AbFero Pharmaceuticals, Inc.

November 11, 2021

Pharmaceuticals

Pharmacosmos A/S (Pharmacosmos Group) has agreed to acquire all assets of Boston-based clinical-stage AbFero Pharmaceuticals, Inc. under a share purchase agreement for up to $225 million including upfront, milestone, and royalty components. The acquisition adds AbFero’s SP-420 iron chelation program to Pharmacosmos’ iron-metabolism-focused R&D and commercial capabilities to accelerate development and commercialization for transfusional iron overload and related indications.

Merck Acquires Acceleron Pharma for $11.5 Billion

September 30, 2021

Biotechnology

Merck has entered into a definitive agreement to acquire Acceleron Pharma Inc. for $180 per share in cash, representing an approximate total equity value of $11.5 billion. The acquisition brings Acceleron's late-stage sotatercept program (for pulmonary arterial hypertension) and its REBLOZYL portfolio into Merck's cardiovascular pipeline, subject to tender offer completion and customary regulatory approvals.

Bora Pharmaceuticals Acquires Upsher-Smith Laboratories

August 5, 2025

Pharmaceuticals

Bora Pharmaceuticals completed a 2024 acquisition of Upsher-Smith Laboratories for $210 million and is expanding the Maple Grove, Minnesota manufacturing site with a multi-year buildout. The investment includes installation of a Gerteis Macro-Pactor (operational Q3 2025) and development of 100,000 square feet of shell space to boost oral solid dose (OSD) contract development and manufacturing capabilities.

BD Acquires Parata Systems

July 18, 2022

Medical Devices

BD (Becton, Dickinson and Company) has completed its acquisition of Parata Systems, a provider of pharmacy automation and medication management solutions. The deal brings Parata into BD's Medication Management Solutions business to expand BD's smart, connected care capabilities across retail, hospital and long-term care pharmacies.

Angus Chemical Company Acquires Expression Systems, LLC

November 9, 2022

Biotechnology

Angus Chemical Company (a PE-backed specialty ingredients manufacturer) has acquired Expression Systems, LLC, a Davis, California-based maker of cell culture media, baculovirus reagents, cell lines and related contract services. The acquisition expands Angus' life‑sciences capabilities into specialty cell culture media and strengthens its bioprocessing product and service offering; Achelous Partners served as exclusive advisor to Expression Systems.